Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

Alvotech has entered key supply and commercialization agreements with Sandoz to expand biosimilar treatments in Canada and across Australia and New Zealand. The deal covers multiple therapeutic areas—ophthalmology, immunology, and gastroenterology—and positions both companies to broaden patient access through shared responsibilities in development, manufacturing, and distribution.

Key Takeaways:

• Alvotech-Sandoz Partnership
• Coverage Spans Canada, Australia, and New Zealand
• Biosimilar Focus for Ophthalmology, Immunology, and Gastroenterology
• Alvotech Oversees Development and Manufacturing; Sandoz Leads Commercialization
• Agreements Aim to Strengthen Patient Access to Affordable Treatments

The Biosimilar Deal in Focus

Alvotech, a global biotechnology company specializing in the development and manufacture of biosimilar medicines, signed supply and commercialization agreements with Sandoz, a firm dedicated to improving patient access to biologic treatments. According to Alvotech, these partnerships aim to broaden patient access across critical markets and strengthen its portfolio in anticipation of regulatory approvals.

Regional Coverage and Therapeutic Areas

In Canada, the arrangement centers on a biosimilar candidate in ophthalmology: a prefilled syringe intended for intravitreal injection. Meanwhile, in Australia and New Zealand, Alvotech and Sandoz have committed to advancing three biosimilar candidates designed for immunology and gastroenterology needs. Each of these products is intended to address specific patient demands in the region.

Shared Responsibilities

“These agreements with Sandoz further advance Alvotech’s strategy of securing commercial pathways for its biosimilars portfolio across global markets ahead of regulatory approval,” said Róbert Wessman, Chairman. Under the deal, Alvotech remains in charge of the research, development, and global clinical activities, as well as manufacturing the biosimilar products. Sandoz takes on the role of managing regulatory submissions, commercialization efforts, and distribution across each of the designated territories.

Key Biosimilar Highlights

Biosimilar Name Therapy Area Territories
Candidate 1 Ophthalmology Canada
Candidate 2 Immunology/Gastro Australia & New Zealand
Candidate 3 Immunology/Gastro Australia & New Zealand
Candidate 4 Immunology/Gastro Australia & New Zealand

(Note: Candidate names and additional details remain undisclosed; this table summarizes the therapy areas and coverage based on the original announcement.)

Patient Access and Global Outlook

Sandoz, known for its commitment to delivering affordable biologic medicines, will helm the distribution of these biosimilars with the support of Alvotech’s development infrastructure. Both companies highlight that this collaboration is intended to bolster patient access by introducing more sustainable, cost-effective treatment options once regulatory approvals are secured.

The agreements underscore the continued momentum in the biosimilars market, suggesting a growing emphasis on collaboration to expand global reach. As these partnerships progress, Alvotech and Sandoz hope their joint effort will serve as a model for future initiatives aimed at delivering vital healthcare products worldwide.

More from World

A Veteran Honored: MHH’s Salute to Service
by Henryherald
1 week ago
2 mins read
Maj. Thomas Bush Agerton III honored as Veteran of the Year
Yangtze River: Safeguarding a Cultural Legacy
by The Chronicle
1 week ago
2 mins read
Experts Gather in Nanjing to Explore the Cultural Heritage of the Yangtze River
ZIGRAM Joins FinTech PH to Fight Financial Crime
by Ein Presswire
1 week ago
2 mins read
ZIGRAM Joins FinTech Alliance.PH to Strengthen Financial Crime Prevention
Alex Eala's WTA Rankings Rise
by Yahoo! News
1 week ago
2 mins read
How Alex Eala’s ranking points total from 2026 compares to her 2025 season
Lawmakers Seek to Impeach Defense Secretary
by Wcvb
1 week ago
1 min read
Understanding the impeachment process for government officials
Where's Korda After Beating Alcaraz?
by Yahoo! News
1 week ago
2 mins read
He is the American player who beat Carlos Alcaraz this year but has now dropped out of the ATP top 100
Racing Bulls: 2027 Driver Line-Up Imminent
by Yahoo! News
1 week ago
2 mins read
Permane wants Lawson decision done: ‘I want you guys to stop asking me’
Iowa State Fair Expands Veteran Memorial
by Kimt News
1 week ago
1 min read
Iowa State Fair expands veteran memorial with personalized bricks
The Future of USMNT: Five Coaches to Watch
by Sports Illustrated
1 week ago
2 mins read
Five Potential Replacements for USMNT Boss Mauricio Pochettino Amid Man Utd Links
Surplus City Cleanup: Final Tests Begin
by Tribune Star
1 week ago
2 mins read
Surplus City hazard cleanup ongoing
Don Trout Faces New Grand Jury Review
by Finger Lakes Times
1 week ago
2 mins read
Trout case to be re-presented to new grand jury
Neuer's Season Struggles Spark Retirement Speculation
by Bayern Munich
1 week ago
2 mins read
Bayern Munich assuming Manuel Neuer will retire this summer